Bidirectional enhancing activities between human T cell leukemia-lymphoma virus type I and human cytomegalovirus in human term syncytiotrophoblast cells cultured in vitro.
The syncytiotrophoblast layer of the human placenta has an important role in limiting transplacental viral spread from mother to fetus. Human cytomegalovirus (HCMV) is capable of establishing a latent infection in syncytiotrophoblast cells, with restriction of gene expression to immediate-early and early proteins. We analyzed the extent of replication of human T cell leukemia-lymphoma virus type I (HTLV-I) in human term syncytiotrophoblasts infected with HTLV-I alone or coinfected with HTLV-I and HCMV. Although syncytiotrophoblasts could be infected with cell-free HTLV-I, no viral protein expression was found in the singly infected cells. On the contrary, coinfection of the cells with HTLV-I and HCMV resulted in simultaneous replication of both viruses. Bidirectional enhancing activities between HTLV-I and HCMV were mediated primarily by the Tax and immediate-early proteins, respectively. The stimulatory effect of HTLV-I Tax on HCMV replication appeared to be mediated partly by tumor necrosis factor beta and transforming growth factor beta-1. We observed formation of pseudotypes with HTLV-I nucleocapsids within HCMV envelopes, whereas HCMV was not pseudotyped by HTLV-I envelopes in dually infected syncytiotrophoblast cells. Our data suggest that in vivo dual infection of syncytiotrophoblast cells with HTLV-I and HCMV may facilitate the transplacental transmission of both viruses.
Tóth
F D
FD
Department of Virus and Cancer, Danish Cancer Society, Aarhus, Denmark.
Aboagye-Mathiesen
G
G
Szabó
J
J
Liu
X
X
Mosborg-Petersen
P
P
Kiss
J
J
Hager
H
H
Zdravkovic
M
M
Andirkó
I
I
Aranyosi
J
J
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001483:Base Sequence; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis; D003587:Cytomegalovirus / Q000254:growth & development* / Q000472:pathogenicity; D016356:Gene Products, tax / Q000502:physiology; D015368:Human T-lymphotropic virus 1 / Q000254:growth & development* / Q000472:pathogenicity; D006801:Humans; D017874:Immediate-Early Proteins / Q000276:immunology / Q000502:physiology; D007106:Immune Sera; D007376:Interleukin-2 / Q000276:immunology / Q000502:physiology; D008233:Lymphotoxin-alpha / Q000276:immunology / Q000502:physiology; D008969:Molecular Sequence Data; D010920:Placenta / Q000821:virology*; D016133:Polymerase Chain Reaction; D016212:Transforming Growth Factor beta / Q000276:immunology / Q000502:physiology; D017735:Virus Latency; D014779:Virus Replication
D000911:Antibodies, Monoclonal; D016207:Cytokines; D016356:Gene Products, tax; D017874:Immediate-Early Proteins; D007106:Immune Sera; D007376:Interleukin-2; D008233:Lymphotoxin-alpha; D016212:Transforming Growth Factor beta